top of page
istockphoto-656519184-612x612.jpg

Participate in a clinical trial

To become a participant in any of our Research Study, please complete this form and submit. 

1819 Buford Hwy, Buford, GA 30518

Phone

678-689-4046

Email

bbonsu@divinityresearchsite.com

www.divinityresearchsite.com

Thanks for submitting!

© 2021 Buford MaxWell Clinic PC

bda841_3f1f7e0b0531470098577e7af739f01f~mv2.jpeg.webp

What is Clinical Research?

Visit our Clinical Trials site www.divinityresearchsite.com

Clinical study is a process that ultimately help doctors find new and effective ways to stop, detect, diagnose, control, and treat illnesses. A clinical research study is conducted through subjects who are volunteers willing to partake in advancing drug. 

Clinical Trials must follow Good Manufacturing Practice guidelines (GCP) created by International Conference of Harmonization (ICH).  All Clinical trials must also follow Food and Drug Administration (FDA) guidelines as well as Institutional Review Board (IRB) ethics guidelines, to ensure the rights, safety and welfare of the subjects involved in the clinical Research Study. Careful oversight and patient care steer the trial toward meaningful outcomes.

The Food and Drug Administration (FDA) requires clinical trials to be conducted on all new or improved drugs and new medical devices that usually falls under Class III device, before it can be approved to be available for the public use. Before a new drug reaches a clinical research trial, researchers spent many years testing, to determine the medication’s safety, risks, and efficacy. 

Why all people including  people of color should partake in clinical research? 

​

Participation Promotes Medical Impartiality​

Clinical trials participants are the key to creating medical advancement, so is diversity among those participants. 

To progress and promote equality in health care, it is essential that all people, including people of color, partake in clinical research studies.  This is because

race, disability and socioeconomic standing, and other demographic reasons can affect folk’s risk of developing certain medical conditions.

It can also affect how they respond to medical interventions and their overall health results. 

As more diverse group participants partake in clinical research trials, there is the likeliness that trial results and any decisions to begin or end clinical treatments will be applied to a diverse group of patients.  

It is also essential that research students represent the people who are most affected by the illness or condition under investigation. For instance, certain cancers and sickle cell illness are  frequent among people of color.  Hence, it's crucial that people of color participate in clinical studies of these serious illnesses. 

A recent evaluation of government-funded cancer research studies concluded  that all racial and ethnic minorities were extremely underrepresented. Additionally,  fewer than 2 percent of these clinical trials centers more on the needs of minorities

bottom of page